Product Code: ETC13227174 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Delirium Market was valued at USD 1.5 Billion in 2024 and is expected to reach USD 2.4 Billion by 2031, growing at a compound annual growth rate of 6.20% during the forecast period (2025-2031).
The global delirium market is witnessing growth due to the increasing prevalence of delirium among the aging population, particularly in hospitals and long-term care facilities. Delirium is a common and serious condition characterized by sudden onset confusion, changes in cognition, and disturbances in consciousness. The market is driven by the rising awareness about delirium among healthcare professionals, advancements in diagnostic technologies, and the development of novel treatment options. Additionally, the growing healthcare expenditure, improving healthcare infrastructure, and supportive government initiatives are expected to further boost market growth. Key players in the global delirium market are focusing on research and development activities to introduce innovative therapies and improve patient outcomes, thereby contributing to the overall market expansion.
The Global Delirium Market is experiencing growth due to increasing awareness about delirium among healthcare professionals and the general public. The rising geriatric population, coupled with the prevalence of chronic diseases that increase the risk of delirium, is driving market demand. Technological advancements in diagnostic tools and treatment options are also contributing to market growth. Opportunities lie in the development of innovative pharmaceuticals and non-pharmacological interventions for delirium management. Additionally, there is a growing focus on early detection and prevention strategies, creating avenues for market expansion. Collaboration between healthcare providers, researchers, and pharmaceutical companies to address the unmet needs in delirium care presents further opportunities for market development. Overall, the Global Delirium Market is poised for continued growth and innovation.
The Global Delirium Market faces several challenges, including underdiagnosis and misdiagnosis due to the complexity of delirium symptoms, lack of awareness among healthcare professionals, and the need for improved screening tools. Additionally, there is a lack of specific treatments for delirium, with current management strategies focusing on symptom control rather than addressing the underlying causes. The high prevalence of delirium in older adults and hospitalized patients also poses a challenge in terms of healthcare costs and resource allocation. Furthermore, the stigma associated with delirium and a general lack of understanding about the condition contribute to delays in diagnosis and suboptimal care for affected individuals. Overall, addressing these challenges will require increased education, research efforts, and improved clinical practices in the field of delirium management.
The global delirium market is primarily driven by an increasing prevalence of delirium among the aging population, particularly in healthcare settings such as hospitals and long-term care facilities. The rising awareness about delirium among healthcare professionals and the general public has also contributed to the growth of this market. Additionally, advancements in diagnostic technologies and treatment options for delirium are further driving market expansion. Furthermore, the growing emphasis on early detection and management of delirium to improve patient outcomes and reduce healthcare costs is fueling market growth. Overall, the increasing focus on addressing delirium as a critical healthcare issue is expected to propel the global delirium market in the coming years.
Government policies related to the Global Delirium Market focus on increasing awareness, education, and research funding to address the growing prevalence and impact of delirium on healthcare systems and patients. Governments are implementing initiatives to improve delirium identification and management in clinical settings, as well as promoting the development of guidelines and protocols for healthcare professionals. Additionally, there is a push for increased collaboration between healthcare providers, researchers, and policymakers to drive innovation and improve outcomes for delirium patients. Government policies also aim to enhance data collection and reporting mechanisms to better understand the economic burden of delirium and inform future policy decisions. Overall, these efforts seek to improve the quality of care for individuals with delirium and reduce the associated healthcare costs.
The Global Delirium Market is expected to witness significant growth in the coming years, driven by increasing awareness about delirium among healthcare professionals and the general population. The aging population, rising prevalence of chronic diseases, and advancements in medical technology are also contributing factors. Moreover, the emphasis on early diagnosis and management of delirium in healthcare settings will fuel market growth. Pharmaceutical companies are investing in research and development to introduce innovative treatment options for delirium, further boosting market expansion. Additionally, the integration of digital health solutions and telemedicine in delirium management is anticipated to create new opportunities in the market. Overall, the Global Delirium Market is poised for steady growth in the foreseeable future.
In the global delirium market, Asia is expected to exhibit significant growth due to the rising geriatric population and increasing awareness about delirium among healthcare professionals. North America is anticipated to lead the market owing to advanced healthcare infrastructure and higher healthcare expenditure. Europe is also a key market for delirium management with a focus on research and development activities. In the Middle East and Africa region, the market is poised to grow steadily due to improving healthcare facilities and government initiatives. Latin America is projected to witness growth as awareness about delirium increases and healthcare systems become more sophisticated. Overall, the global delirium market is experiencing growth across all regions, driven by increasing prevalence of delirium and rising demand for effective treatment options.
Global Delirium Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Delirium Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Delirium Market Revenues & Volume, 2021 & 2031F |
3.3 Global Delirium Market - Industry Life Cycle |
3.4 Global Delirium Market - Porter's Five Forces |
3.5 Global Delirium Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Delirium Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Global Delirium Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Delirium Market Trends |
6 Global Delirium Market, 2021 - 2031 |
6.1 Global Delirium Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Delirium Market, Revenues & Volume, By Suvorexant, 2021 - 2031 |
6.1.3 Global Delirium Market, Revenues & Volume, By CN 105, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.3.1 Overview & Analysis |
7 North America Delirium Market, Overview & Analysis |
7.1 North America Delirium Market Revenues & Volume, 2021 - 2031 |
7.2 North America Delirium Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Delirium Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Delirium Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Delirium Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Delirium Market, Revenues & Volume, By Drugs, 2021 - 2031 |
8 Latin America (LATAM) Delirium Market, Overview & Analysis |
8.1 Latin America (LATAM) Delirium Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Delirium Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Delirium Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Delirium Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Delirium Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Delirium Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Delirium Market, Revenues & Volume, By Drugs, 2021 - 2031 |
9 Asia Delirium Market, Overview & Analysis |
9.1 Asia Delirium Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Delirium Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Delirium Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Delirium Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Delirium Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Delirium Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Delirium Market, Revenues & Volume, By Drugs, 2021 - 2031 |
10 Africa Delirium Market, Overview & Analysis |
10.1 Africa Delirium Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Delirium Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Delirium Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Delirium Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Delirium Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Delirium Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Delirium Market, Revenues & Volume, By Drugs, 2021 - 2031 |
11 Europe Delirium Market, Overview & Analysis |
11.1 Europe Delirium Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Delirium Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Delirium Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Delirium Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Delirium Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Delirium Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Delirium Market, Revenues & Volume, By Drugs, 2021 - 2031 |
12 Middle East Delirium Market, Overview & Analysis |
12.1 Middle East Delirium Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Delirium Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Delirium Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Delirium Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Delirium Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Delirium Market, Revenues & Volume, By Drugs, 2021 - 2031 |
13 Global Delirium Market Key Performance Indicators |
14 Global Delirium Market - Export/Import By Countries Assessment |
15 Global Delirium Market - Opportunity Assessment |
15.1 Global Delirium Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Delirium Market Opportunity Assessment, By Drugs, 2021 & 2031F |
16 Global Delirium Market - Competitive Landscape |
16.1 Global Delirium Market Revenue Share, By Companies, 2024 |
16.2 Global Delirium Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |